Expression of Notch1, MMP-2 and MMP-9 and their significance in glioma patients

Chinese Journal of Oncology

Volumn 34, Issue 1, 2012, Pages 26-30

  Sun, Zeng Feng ^a   Wang, Le ^b   Gu, Feng ^b   Fu, Li ^b   Li, Wen Liang ^b   Ma, Yong Jie ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

Glioma; Matrix metalloproteinase 2; Matrix metalloproteinase 9; Notch1; Prognosis

Indexed keywords

GELATINASE A; GELATINASE B; NOTCH1 RECEPTOR;

ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; ENZYME REGULATION; FOLLOW UP; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; SURVIVAL TIME;

EID: 84863074454     PISSN: 02533766     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0253-3766.2012.01.006     Document Type: Article

References (16)

1. Stylianou S, Clarke RB, Brennan K. Aberrant activation of notch signaling in human breast cancer. Cancer Res, 2006, 66:1517-1525. (Pubitemid 43259933)
2. Radtke F, Raj K. The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat Rev Cancer, 2003, 3:756-767. (Pubitemid 37328814)
3. Hatakeyama J, Sakamoto S, Kageyama R. Hes1 and Hes5 regulate the development of the cranial and spinal nerve systems. Dev Neurosci, 2006, 28:92-101.
4. Leong KG, Karsan A. Recent insights into the role of Notch signaling in tumorigenesis. Blood, 2006, 107:2223-2233. (Pubitemid 43345539)
5. Mullendore ME, Koorstra JB, Li YM, et al. Ligand-dependent Notch signaling is involved in tumor initiation and tumor maintenance in pancreatic cancer. Clin Cancer Res, 2009, 15:2291-2301.
6. Sivasankaran B, Degen M, Ghaffari A, et al. Tenascin-C is a novel RBPJkappa-induced target gene for Notch signaling in gliomas. Cancer Res, 2009, 69:458-465.
7. Liu ZJ, Shirakawa T, Li Y, et al. Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis. Mol Cell Biol, 2003, 23:14-25. (Pubitemid 36008497)
8. Chigurupati S, Venkataraman R, Barrera D, et al. Receptor channel TRPC6 is a key mediator of Notch-driven glioblastoma growth and invasiveness. Cancer Res, 2010, 70:418-427.
9. Wang Z, Banerjee S, Li Y, et al. Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. Cancer Res, 2006, 66:2778-2784.
10. Wang Z, Zhang Y, Banerjee S, et al. Inhibition of nuclear factor kappab activity by genistein is mediated via Notch-1 signaling pathway in pancreatic cancer cells. Int J Cancer, 2006, 118:1930-1936.
11. Forsyth PA, Wong H, Laing TD, et al. Gelatinase-A (MMP-2), gelatinase-B(MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br J Cancer, 1999, 79:1828-1835. (Pubitemid 29132312)
12. Komatsu K, Nakanishi Y, Nemoto N, et al. Expression and quantitative analysis of matrix metalloproteinase-2 and -9 in human gliomas. Brain Tumor Pathol, 2004, 21:105-112. (Pubitemid 40187984)
13. Kachra Z, Beaulieu E, Delbecchi L, et al. Expression of matrix metalloproteinases and their inhibitors in human brain tumors. Clin Exp Metastasis, 1999, 17:555-566. (Pubitemid 30337129)
14. Kondraganti S, Mohanam S, Chintala SK, et al. Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion. Cancer Res, 2000, 60:6851-6855. (Pubitemid 32059151)
15. Delbosc S, Glorian M, Le Port AS, et al. The benefit of docosahexanoic acid on the migration of vascular smooth muscle cells is partially dependent on Notch regulation of MMP-2/-9. Am J Pathol, 2008, 172:1430-1440. (Pubitemid 351671555)